CCAIM
Novel AI to transform healthcare
Sarah Teichmann, a Principal Investigator for CCAIM and Head of Cellular Genetics at the Wellcome Sanger Institute, is recognised for her pioneering computational biology and genomics work, which led to …
Centre Director, Professor Mihaela van der Schaar, announces a breakthrough: a partnership between her Cambridge lab and NHS Digital and Public Health England, to trial Cambridge Adjutorium – a system …
CCAIM Director, Professor Mihaela van der Schaar, explains that using AI and machine learning in medicine isn’t just about developing accurate models and rolling them out because, on their own, …
CCAIM Director, Professor Mihaela van der Schaar, demonstrates that machine learning techniques can accurately predict how covid-19 will impact hospital resource needs, such as ventilators and ICU beds at the …
CCAIM Director, Professor Mihaela van der Schaar, calls on governments and healthcare authorities to use proven AI and machine learning techniques and existing data to coordinate a response to the …
The covid-19 pandemic led to unprecedented strain on intensive care unit admission. CCAIM’s Dr Ari Ercole discusses his work on ultra-early forecasting of that strain on intensive care resources. Read …
Working with the Cystic Fibrosis Trust, CCAIM Director Mihaela van der Schaar’s team developed machine learning methods that could dramatically improve the accuracy of clinical assessments of people with cystic …
World-leading expertise in healthcare-focused machine learning combined with the world’s largest, high-quality cancer data collection service could lead to a quantum leap in personalised medicine. (This article, featuring the work …
